RE:ValuationsAbsolutely agree . My thoughts are they want down to finance and grab as many shares as possible, as anyone would know they have info. that us longs would never hear about , one would also think that get this PMN310 in trials get good info and the stock should go up then issue shares to support the trial. The other MAB diffently need partners to advance , it was stated 1 billion if they have the goods this is worth Billions , Gene said about 5 yrs. ago that they spent more on high end MAB's that at the end of phase 1 PMN310 was worh 16 Billion , so what would the keys of the kingdom be worth . Acumen states that the Wall Street Journal says AD market a 100 billion market . Also OMN states a effort is underway to improve there Algorithms with machine learning capabilities to accelerate our ability to indentify and patent DSE's and antibodies across neurodegenerative and other diseases.